View in EDS HTML Full Text PDF Full Text

Study Design and Baseline Characteristics of the VERINA Study: Phase IV Evidence of Vericiguat for Worsening Heart Failure Management.

Saved in:
Bibliographic Details
Title: Study Design and Baseline Characteristics of the VERINA Study: Phase IV Evidence of Vericiguat for Worsening Heart Failure Management.
Authors: Abdulakutty, Jabir1 (AUTHOR) drjabi@yahoo.co.in, Abhyankar, Atul2 (AUTHOR), Seth, Sandeep3 (AUTHOR), Sharma, Kamal4 (AUTHOR), Aggarwal, Rakesh Kumar5 (AUTHOR), Bhalani, Nirav6 (AUTHOR), Vijan, Vinod7 (AUTHOR), Bansal, Sandeep8 (AUTHOR), Jain, Rajendra Kumar Premchand9 (AUTHOR), Banerjee, Suvro10 (AUTHOR), Chopra, V. K.11 (AUTHOR), Oomman, Abraham12 (AUTHOR), Kahale, Pravin13 (AUTHOR), Sodhi, Priyanka14 (AUTHOR), Gawde, Ashish14 (AUTHOR)
Source: Cardiology & Therapy. Mar2026, Vol. 15 Issue 1, p83-99. 17p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:21938261
DOI:10.1007/s40119-025-00442-4